"Take one deliberately undercooked cancer experiment, publish a scientific paper to promote its academically ridiculed findings, and go on a world tour to publicise its conclusions, and what do you get? In the case of Dr David Bernstein, the asbestos industry's go-to scientist, the answer is several million dollars. One 2003 study alone was financed with $1 million from the Chrysotile Institute, at the time the lead body for the industry lobby worldwide. It formed the basis of what David Egilman, editor-in-chief of the International Journal of Occupational and Environmental Health (IJOEH), called the asbestos industry's enduring ABC – Anything But Chrysotile – myth. The Bernstein paper argued that because chrysotile was less “biopersistent” than other forms of asbestos, it could be used safely. ..."

Support: Digital